Showing results (351-360 of 3,241) with videos related to
Sort By:
Pageof 325
Journal of Clinical Pharmacy and Therapeutics|June 11, 2003
Use of pharmacoeconomics in prescribing research. Part 3: Cost-effectiveness analysis--a technique for decision-making at the marginR Lopert, D L Lang, S R HillJournal of Clinical Pharmacy and Therapeutics|August 9, 2001
Isoprostane 8-epi-PGF2alpha is frequently increased in patients with muscle pain and/or CK-elevation after HMG-Co-enzyme-A-reductase inhibitor therapyH Sinzinger, G Lupattelli, F Chehne, et al.Journal of Clinical Pharmacy and Therapeutics|June 1, 1992
Phage typing of coagulase-negative staphylococciP Boussard, A Pithsy, M J Devleeschouwer, et al.Journal of Clinical Pharmacy and Therapeutics|May 15, 2001
Bioequivalence of allopurinol and its metabolite oxipurinol in two tablet formulationsP Guerra, J Frias, B Ruiz, et al.Journal of Clinical Pharmacy and Therapeutics|February 1, 1992
High-performance liquid chromatographic determination of floctafenine and its major metabolite, floctafenic acid in plasmaM H Abdel-Hay, A M GharaibehJournal of Clinical Pharmacy and Therapeutics|April 22, 2017
Evaluation of real-time data obtained from gravimetric preparation of antineoplastic agents shows medication errors with possible critical therapeutic impact: Results of a large-scale, multicentre, multinational, retrospective studyR Terkola, M Czejka, J BérubéJournal of Clinical Pharmacy and Therapeutics|October 18, 2018
Use of gastric-acid suppressants may be a risk factor for enteric peritonitis in patients undergoing peritoneal dialysis: A meta-analysisHao-Jie Zhong, Da Lin, Zhi-Yong Lu, et al.Journal of Clinical Pharmacy and Therapeutics|June 1, 1994
Therapeutic progress. I: Current treatment of rheumatoid arthritisN J GittoesJournal of Clinical Pharmacy and Therapeutics|June 1, 1994
Advances in pharmacotherapy: treatment of hypertensive crisisD S McKindley, B A BoucherJournal of Clinical Pharmacy and Therapeutics|June 1, 1994
Bioequivalence of two oral dosage forms prepared from different polymorphic modifications of tenoxicamM S Salem, H N Alkaysi, A M Gharaibeh, et al.Pageof 325